Inside informationEnglish
Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 22/09/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 119076_20250922